US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

36.57

-0.2300-0.62%

Post-market: 36.570.00000.00%19:30 EDT

Volume:21.69K

Turnover:793.57K

Market Cap:95.45M

PE:- -

High:36.78

Open:36.78

Low:36.42

Close:36.80

52wk High:36.84

52wk Low:23.32

Shares:2.61M

Float Shares:2.61M

Volume Ratio:0.26

T/O Rate:0.83%

Dividend:0.26

Dividend Rate:0.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

TScan Therapeutics Faces Loss of Key Amgen Partnership

TScan Therapeutics - Amgen to Terminate Research Collaboration and License Agreement with TScan Therapeutics - SEC Filing

THOMSON REUTERS

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Vortex Energy Finalizes 3D Tomography Study at Robinsons River Salt Project

Gilead Sciences Inc Stock (GILD) Moved Up by 3.14% on Aug 18: Drivers Behind the Movement

Betta Pharma Announces LUGANO Trial Misses Primary Endpoint for DURAVYU in Wet AMD

Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital

Trump's Privateer Hacking Plan Brings High Risk to Companies Taking Part

Genprex selects manufacturing organization for diabetes gene therapy

HBM Holdings Secures NMPA Clearance for HBM7004 IND in Advanced Solid Tumors

Hong Kong Stock Market Flash | Micot Pharma-B (02335) Surges Nearly 6% in Afternoon Session as Innovative Drug XTL6001 Makes Third Appearance on International Academic Stage

Jiangsu Nhwa Pharmaceutical's Innovative Drug NH302 Injection Cleared for Clinical Trials

CANbridge Wins Taiwan NHIA Reimbursement for Rare Disease Drug Livmarli

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Vortex Energy Appoints Market Maker to Boost Liquidity on CSE

Regeneron Pharma Price Target Raised to $824.00/Share from $641.00 by Leerink Partners

EyePoint Tumbles After Experimental Eye Drug Misses Main Goal in Late-Stage Study

Vertex (VERX) Is Up 6.5% After Q2 Profit, Raised 2026 Outlook And New AI-Focused Hires

Simply Wall St.

Innovative Drug Sector's Rally from Lows Faces Divergence as Sustainability Hinges on Commercialization Proof

Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/IBBQ/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":36.57,"timestamp":1787774400000,"preClose":36.8,"halted":0,"volume":21693,"hourTrading":{"tag":"盘后","latestPrice":36.57,"preClose":36.57,"latestTime":"19:30 EDT","volume":138,"amount":5035.788,"timestamp":1787787003652,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006249999999999915,"floatShares":2610001,"shares":2610001,"eps":0,"marketStatus":"Not Yet Opened","change":-0.23,"latestTime":"08-26 16:00:00 EDT","open":36.78,"high":36.78,"low":36.42,"amount":793570.4408310001,"amplitude":0.009783,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":36.8,"sharesOutstanding":2520001,"nav":36.70729,"aum":95806063.60729,"dividendRate":0.007044,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.76,"preClose":36.8,"latestTime":"09:29 EDT","volume":101,"amount":3712.795653,"timestamp":1787750998097,"change":-0.04,"changeRate":-0.001087,"amplitude":0.00097},"postHourTrading":{"tag":"盘后","latestPrice":36.57,"preClose":36.57,"latestTime":"19:30 EDT","volume":138,"amount":5035.788,"timestamp":1787787003652,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.260535,"impliedVol":0.0839,"impliedVolPercentile":0.3466},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2610001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.260535,"shares":2610001,"dividePrice":0.2576,"high":36.78,"amplitude":0.009783,"preClose":36.8,"low":36.42,"week52Low":23.315,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":36.57,"eps":0,"divideRate":0.007044,"volume":21693,"delay":0,"ttmEps":0,"open":36.78,"prevYearClose":28.3962,"prevWeekClose":36.29,"prevMonthClose":32.1008,"prevQuarterClose":32.66,"fiveDayClose":36.8205,"twentyDayClose":32.41,"sixtyDayClose":29.2526},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660497970","title":"TScan Therapeutics Faces Loss of Key Amgen Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2660497970","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660497970?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:32","pubTimestamp":1787088742,"startTime":"0","endTime":"0","summary":"TScan Therapeutics ( ($TCRX) ) has shared an announcement. On August 12, 2026, TScan Therapeutics said that Amgen had exercised its right to termin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tscan-therapeutics-faces-loss-of-key-amgen-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tscan-therapeutics-faces-loss-of-key-amgen-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4588","BK4139","IE00B2B36J28.USD","TCRX","BK4581","PJP","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4534","LU0868494617.USD","LU1061106388.HKD","IE0009355771.USD","LU2089984988.USD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","LU0109394709.USD","BK4539","LU1571399168.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2242652126.USD","LU0889565916.HKD","BK4533","LENZ","LU2468319806.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1023059063.AUD","BK4599","LU0289739699.SGD","BK4585","LU2112291526.USD","BIB","IBBQ","LU0122379950.USD","IE00BFTCPJ56.SGD","AMGN","IE00B4R5TH58.HKD","BK4007","TBXU","BBH","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492015","title":"TScan Therapeutics - Amgen to Terminate Research Collaboration and License Agreement with TScan Therapeutics - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492015?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:03","pubTimestamp":1787086998,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F15X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","BK4588","BK4139","IE00B2B36J28.USD","TCRX","BK4581","PJP","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4534","LU0868494617.USD","LU1061106388.HKD","IE0009355771.USD","LU2089984988.USD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","LU0109394709.USD","BK4539","LU1571399168.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2242652126.USD","LU0889565916.HKD","BK4533","LU2468319806.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1023059063.AUD","BK4599","LU0289739699.SGD","BK4585","LU2112291526.USD","BIB","IBBQ","LU0122379950.USD","IE00BFTCPJ56.SGD","AMGN","IE00B4R5TH58.HKD","TBXU","BBH","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492601","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492601?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:36","pubTimestamp":1787085360,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 3.25% to $143.44 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.69% to 7,691.76 and Dow Jones Industrial Average  falling 0.22% to 53,343.40.This was the stock's sixth consecutive day of gains.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company reached on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 3.33% to $271.11, Pfizer Inc.  rose 1.41% to $27.25, and Abbott Laboratories  rose 2.09% to $112.68.Trading volume  remained 1.9 million below its 50-day average volume of 7.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","LU0823416689.USD","LU0289739699.SGD","LU1934455194.USD","BIB","BBH","LU2324357040.USD","BK4550","LU2468319806.SGD","SG9999015945.SGD","TBXU","BK4578","LU0889565916.HKD","LU1585245621.USD","LU0320765992.SGD","LU1778281490.HKD","LU0882574055.USD","LU0234570918.USD","LU0965509283.SGD","MEDI","BK4585","IE00B7SZLL34.SGD","BK4139","LU1037948897.HKD","LU1066053197.SGD","BK4583","BK4532","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0965508806.USD","LU1430594728.SGD","LU1839511570.USD","IBB","LU1674673428.USD","LU2087621335.USD","BK4588","BK4566","LU0965509101.SGD","LU0114720955.EUR","LU0861579265.USD","LU1057294990.SGD","LU1934455863.HKD","SG9999015986.USD","LU2112291526.USD","IE0002270589.USD","LU1023059063.AUD","LU1674673691.USD","LU1066051498.USD","LU2089984988.USD","LU1571399168.USD","SG9999015978.USD","LU0058720904.USD","TMED","LU1037948541.HKD","GILD","BMED","IE00BKVL7J92.USD","IE00B3T34201.USD","BK4568","LU1061106388.HKD","LU1934455277.USD","SG9999015952.SGD","LU0109394709.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660912244","title":"Vortex Energy Finalizes 3D Tomography Study at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2660912244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660912244?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:47","pubTimestamp":1787078856,"startTime":"0","endTime":"0","summary":"The latest update is out from Vortex Energy Corp. ( ($TSE:VRTX) ). Vortex Energy has released final results from an Ambient Noise Tomography survey...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-finalizes-3d-tomography-study-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-finalizes-3d-tomography-study-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBB","LU1093756325.SGD","LU2362541513.USD","SG9999001176.SGD","TBXU","LU1430594728.SGD","IE00B19Z9P08.USD","LU1674673428.USD","SGXZ57979304.SGD","LU2362540622.SGD","IE00B2B36J28.USD","LU0320765992.SGD","LU0889565916.HKD","IE0002141913.USD","LU2456880835.USD","BIB","IE00B4R5TH58.HKD","IE0009355771.USD","LU0432979614.USD","LU2362541273.HKD","IE00BFTCPJ56.SGD","BBH","LU0234570918.USD","LU0417517546.SGD","SG9999013999.USD","PBE","VRTX","BK4585","LU0256863811.USD","GNMX","IBBQ","LU0061475181.USD","LU2462157665.USD","IE00B894F039.SGD","LU2324357040.USD","BK4588","LU0823416689.USD","SG9999001176.USD","LU1674673691.USD","IDNA","LU2236285917.USD","LU1035775433.USD","LU0109394709.USD","IE00B19Z3581.USD","LU2417539215.USD","LU1069344957.HKD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491075","title":"Gilead Sciences Inc Stock (GILD) Moved Up by 3.14% on Aug 18: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491075","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491075?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:15","pubTimestamp":1787076939,"startTime":"0","endTime":"0","summary":"• A federal court injunction blocks foreign importation of Gilead's key HIV medications.\n• Robust base-business revenue growth and raised guidance drove positive market sentiment.\n• Strategic oncology investments and bullish institutional options activity supported equity momentum.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262115757-market-movers-gild-20260818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00B3T34201.USD","IBBQ","LU0058720904.USD","LU0823416689.USD","LU0965509010.AUD","BK4532","LU0965509283.SGD","LU1585245621.USD","LU1934455194.USD","LU1674673428.USD","LU1061106388.HKD","LU2087621335.USD","LU1057294990.SGD","BK4550","BK4588","LU0109394709.USD","BK4578","LU1934455277.USD","MEDI","BBH","IBB","LU1066051498.USD","LU0882574055.USD","LU1037948541.HKD","GILD","IE00BSNM7G36.USD","BK4583","BK4566","BK4585","BIB","LU1674673691.USD","LU2468319806.SGD","LU0289739699.SGD","LU1934455863.HKD","SG9999015986.USD","TMED","IE00BKVL7J92.USD","LU0965508806.USD","BK4139","LU1430594728.SGD","LU1571399168.USD","SG9999015945.SGD","LU0889565916.HKD","SG9999015978.USD","LU2112291526.USD","BK4568","LU0234570918.USD","IE00B19Z3581.USD","LU0861579265.USD","LU0965509101.SGD","LU0122379950.USD","LU2324357040.USD","LU1778281490.HKD","LU1023059063.AUD","BMED","LU1037948897.HKD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU1839511570.USD","LU0320765992.SGD","TBXU","LU1066053197.SGD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165947471","title":"Betta Pharma Announces LUGANO Trial Misses Primary Endpoint for DURAVYU in Wet AMD","url":"https://stock-news.laohu8.com/highlight/detail?id=1165947471","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165947471?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:28","pubTimestamp":1787063295,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals Co.,Ltd. (300558.SZ) has disclosed that its partner, EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), released data from the LUGANO study, the first of two pivotal Phase III...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300558","BK0239","IBBJ","IBBQ","MDTX","BK0060","BMED","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464901","title":"Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660464901?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:37","pubTimestamp":1787053066,"startTime":"0","endTime":"0","summary":"BMO Capital analyst Evan Seigerman maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $600.00. The company’s sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vertex-pharmaceuticals-vrtx-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vertex-pharmaceuticals-vrtx-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0109394709.USD","SG9999001176.USD","BIB","LU1069344957.HKD","LU1035775433.USD","LU2362540622.SGD","LU2362541273.HKD","LU1559883803.SGD","IBBQ","LU1674673691.USD","VRTX","LU0079474960.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU2417539215.USD","TBXU","BBH","LU2089984988.USD","IE00B2B36J28.USD","LU2236285917.USD","VERX","IE00BJJMRZ35.SGD","BK4023","BK4567","BK4207","LU0823416689.USD","IE0009355771.USD","IDNA","SG9999013999.USD","BMO","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0061475181.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU2324357040.USD","GNMX","IE0002141913.USD","LU1674673428.USD","SGXZ57979304.SGD","PBE","LU1093756168.USD","LU1093756325.SGD","LU0566484027.USD","IE00B19Z9P08.USD","LU0417517546.SGD","SG9999001176.SGD","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660446465","title":"Trump's Privateer Hacking Plan Brings High Risk to Companies Taking Part","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446465","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660446465?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:34","pubTimestamp":1787052840,"startTime":"0","endTime":"0","summary":"Hello. President Trump is asking cybersecurity and tech companies to take on a potentially dangerous new role attacking foreign cybercriminals, but the plan offers few incentives to balance the risks.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE0002141913.USD","BK4547","LU1023059063.AUD","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","LU2242652126.USD","BK4557","BK4585","BK4581","PJP","IBB","LU2242646821.SGD","BK4534","BIB","LU2089984988.USD","TLRY","IE00BFTCPJ56.SGD","SG9999001440.SGD","BK4599","LU1983299246.USD","BK4007","LU0122379950.USD","BBH","IE00BJT1NW94.SGD","IBBQ","BK4566","LU0289739699.SGD","LU1061106388.HKD","TBXU","LU0868494617.USD","LU0320765992.SGD","LU2468319806.SGD","IE0009355771.USD","LU1057294990.SGD","AMGN","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139","LU2112291526.USD","BK4596","BK4533","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461015","title":"Genprex selects manufacturing organization for diabetes gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461015","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461015?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:10","pubTimestamp":1787051418,"startTime":"0","endTime":"0","summary":"Genprex (GNPX) has entered into a development and manufacturing agreement with a U.S. based clinical and commercial Contract Development and Manufa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-selects-manufacturing-organization-for-diabetes-gene-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-selects-manufacturing-organization-for-diabetes-gene-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","BK4585","GNPX","IBBQ","IBB","SYNB","LFSC","BK4588","TBXU","GNOM","FBT","BK4139","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198403419","title":"HBM Holdings Secures NMPA Clearance for HBM7004 IND in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1198403419","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198403419?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:09","pubTimestamp":1787044155,"startTime":"0","endTime":"0","summary":"HBM Holdings-B (02142) has announced that its Investigational New Drug (IND) application for HBM7004, a novel B7H4xCD3 bispecific antibody designed for advanced solid tumors, has been approved by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02142","IBBQ","IBBJ","BMED","PSYK","MDTX","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176624055","title":"Hong Kong Stock Market Flash | Micot Pharma-B (02335) Surges Nearly 6% in Afternoon Session as Innovative Drug XTL6001 Makes Third Appearance on International Academic Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=1176624055","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176624055?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:50","pubTimestamp":1787032215,"startTime":"0","endTime":"0","summary":"MICOT PHARMA-B (02335) jumped nearly 6% in the afternoon session, trading up 5.94% at HK$32.12 with turnover reaching HK$12.68 million at the time of writing.On the news front, the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1574","159992","BK1161","BK4585","IBBQ","MEDX","BK4588","02335","KCAI","VXUS","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116946341","title":"Jiangsu Nhwa Pharmaceutical's Innovative Drug NH302 Injection Cleared for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1116946341","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116946341?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:00","pubTimestamp":1787025628,"startTime":"0","endTime":"0","summary":"Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) has announced that it recently received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for its Class...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002262","BK0188","BK0070","MDTX","159992","BK1161","LU1064131003.USD","LU2148510915.USD","BK1574","MEDX","PSYK","LU1064130708.USD","IBBJ","BK0239","LNGR","06978","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660343035","title":"CANbridge Wins Taiwan NHIA Reimbursement for Rare Disease Drug Livmarli","url":"https://stock-news.laohu8.com/highlight/detail?id=2660343035","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660343035?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:38","pubTimestamp":1787006327,"startTime":"0","endTime":"0","summary":"CANbridge Pharmaceuticals Inc. ( ($HK:1228) ) has shared an update. CANbridge Pharmaceuticals Inc. announced that its rare disease drug Livmarli ha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/canbridge-wins-taiwan-nhia-reimbursement-for-rare-disease-drug-livmarli?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/canbridge-wins-taiwan-nhia-reimbursement-for-rare-disease-drug-livmarli?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","BK4588","IBB","BK4585","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660543294","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2660543294","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660543294?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:34","pubTimestamp":1786998840,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rose 1.00% to $419.38 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.52% to 7,745.06 and Dow Jones Industrial Average  falling 0.51% to 53,459.78.Amgen Inc. closed 0.57% below its 52-week high of $421.79, which the company achieved on August 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.78% to $262.37, Pfizer Inc.  rose 0.30% to $26.87, and AbbVie Inc.  rose 0.35% to $250.33.Trading volume  remained 239,213 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4588","BK4139","IE00B2B36J28.USD","BK4581","PJP","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4534","LU0868494617.USD","04332","IE0009355771.USD","LU1061106388.HKD","LU1983299246.USD","LU2089984988.USD","LU2242646821.SGD","LU0109394709.USD","SG9999001440.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2242652126.USD","LU0889565916.HKD","BK4533","LU2468319806.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1023059063.AUD","BK4599","LU0289739699.SGD","BK4585","LU2112291526.USD","BIB","IBBQ","LU0122379950.USD","IE00BFTCPJ56.SGD","AMGN","IE00B4R5TH58.HKD","TBXU","BBH","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431812","title":"Vortex Energy Appoints Market Maker to Boost Liquidity on CSE","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431812","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431812?lang=en_us&edition=fundamental","pubTime":"2026-08-18 01:07","pubTimestamp":1786986428,"startTime":"0","endTime":"0","summary":"An announcement from Vortex Energy Corp. ( ($TSE:VRTX) ) is now available. Vortex Energy Corp., a North American mineral exploration company, is ad...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-appoints-market-maker-to-boost-liquidity-on-cse?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-appoints-market-maker-to-boost-liquidity-on-cse?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBB","LU2362541513.USD","TBXU","LU1430594728.SGD","IE00B19Z9P08.USD","LU2362540622.SGD","LU0320765992.SGD","LU0889565916.HKD","IE0002141913.USD","BIB","LU2089984988.USD","IE0009355771.USD","LU0432979614.USD","LU2362541273.HKD","IE00BFTCPJ56.SGD","BBH","LU0234570918.USD","LU0417517546.SGD","SG9999013999.USD","PBE","VRTX","BK4585","LU0256863811.USD","GNMX","LU0058720904.USD","IBBQ","BK4533","LU0061475181.USD","LU0079474960.USD","IE00B19Z9Z06.USD","LU2237438978.USD","BK4139","IE00B894F039.SGD","IE0002270589.USD","LU2324357040.USD","BK4588","LU0823416689.USD","SG9999001176.USD","BK4567","IDNA","LU2236285917.USD","LU0109394709.USD","LU1778281490.HKD","IE00B19Z3581.USD","LU2417539215.USD","LU1069344957.HKD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480606","title":"Regeneron Pharma Price Target Raised to $824.00/Share from $641.00 by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480606","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480606?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:45","pubTimestamp":1786970700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434583.USD","IBBQ","LU2362541513.USD","LU2106854487.HKD","BBH","TBXU","BK4588","LU0823434740.USD","REGN","LU0882574055.USD","LU2237438978.USD","LU1974910355.USD","IBB","LU0058720904.USD","LU0823416689.USD","LU0289739699.SGD","LU2468319806.SGD","LU0053666078.USD","LU2362540622.SGD","LU0889565916.HKD","LU0114720955.EUR","BK4139","LU0109394709.USD","LU0320765992.SGD","LU1917777945.USD","LU2023250504.SGD","LU2362541273.HKD","LU2089984988.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487894","title":"EyePoint Tumbles After Experimental Eye Drug Misses Main Goal in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487894","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487894?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:06","pubTimestamp":1786968371,"startTime":"0","endTime":"0","summary":"BUZZ-EyePoint tumbles after experimental eye drug misses main goal in late-stage study** Shares of drug developer EyePointEYPT.Ofell 62.7% to $5.50 premarket** Co says experimental eye drug Duravyumissed the main goalof a late-stage trial against Regeneron's blockbuster eye drug Eylea in patients with wet age-related macular degeneration, a leading cause of vision loss** EYPT says an analysis excluding nine patients whose vision loss was unrelated to wet AMD showed Duravyu performed similarly to Eylea** Co says Duravyu reduced treatment burden by 42% versus Eylea, or about two fewer injections through Week 56** EYPT says 54% of patients were supplement-free through Week 56 and 79% received zero or one supplemental injection** Co expects data from a second late-stage wet AMD study in Q4 2026 and plans a potential FDA filing in H1 2027** As of last close, stock down ~19% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44E0Q6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0823434740.USD","BK4007","LU0889565916.HKD","LU0823434583.USD","LU2362541513.USD","LU0109394709.USD","IBB","REGN","BK4139","LU0882574055.USD","LU0823416689.USD","LU1917777945.USD","LU0320765992.SGD","IBBQ","BK4585","BK4588","LU0289739699.SGD","LU2362540622.SGD","LU0114720955.EUR","LU2362541273.HKD","LU2468319806.SGD","LU1974910355.USD","LU0053666078.USD","EYPT","LU0058720904.USD","BBH","LU2237438978.USD","TBXU","LU2106854487.HKD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660102443","title":"Vertex (VERX) Is Up 6.5% After Q2 Profit, Raised 2026 Outlook And New AI-Focused Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2660102443","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660102443?lang=en_us&edition=fundamental","pubTime":"2026-08-17 12:42","pubTimestamp":1786941762,"startTime":"0","endTime":"0","summary":"In early August 2026, Vertex, Inc. reported second-quarter revenue of US$203.97 million, returning to quarterly profitability, issued updated 2026 guidance, and announced three senior leadership appointments across people, Europe, and product and technology.\nThe combination of stronger quarterly results, clearer near-term revenue expectations, and experienced hires to drive SaaS and AI innovation signals management’s focus on scaling execution and international expansion.\nNext, we’ll examine...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-verx/vertex/news/vertex-verx-is-up-65-after-q2-profit-raised-2026-outlook-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-verx/vertex/news/vertex-verx-is-up-65-after-q2-profit-raised-2026-outlook-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1674673691.USD","LU1778281490.HKD","LU1093756168.USD","IE00B19Z3581.USD","LU1035775433.USD","LU0061475181.USD","LU1585245621.USD","CHAT","LU2237438978.USD","LU1674673428.USD","LU2324357040.USD","LU2362541513.USD","VERX","IDNA","AGIX","LU2362541273.HKD","IE00BJJMRZ35.SGD","QTOC","LU2468319806.SGD","IE0002270589.USD","VRTX","SG9999013999.USD","LU0256863811.USD","LU1093756325.SGD","ARTY","IBBQ","LU1559883803.SGD","LU2462157665.USD","LU0234570918.USD","IE00B2B36J28.USD","TBXU","SG9999001176.SGD","PBE","IE00BJT1NW94.SGD","IE00B894F039.SGD","IBB","LU2362540622.SGD","GNMX","LU0058720904.USD","LU2456880835.USD","BK4567","AIPO","BBH","LU0823416689.USD","VTHR","LU0432979614.USD","LU0079474960.USD","BIB","LU0109394709.USD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121433031","title":"Innovative Drug Sector's Rally from Lows Faces Divergence as Sustainability Hinges on Commercialization Proof","url":"https://stock-news.laohu8.com/highlight/detail?id=1121433031","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121433031?lang=en_us&edition=fundamental","pubTime":"2026-08-16 11:10","pubTimestamp":1786849841,"startTime":"0","endTime":"0","summary":"Despite a rebound and valuation repair in the innovative drug sector since August, driven by oversold conditions, profit-taking and divergent stock performances following earnings results suggest...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1574","MEDX","IBBQ","BK1161","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659417366","title":"Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659417366","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659417366?lang=en_us&edition=fundamental","pubTime":"2026-08-15 21:01","pubTimestamp":1786798870,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($AMGN)), (($CEG)), (($FSLY)), (($KEEL)) and (($BX)). Here is a breakdown of their recent trades and th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/amgen-constellation-fastly-keel-blackstone-shock-wall-st?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/amgen-constellation-fastly-keel-blackstone-shock-wall-st?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FSLY","LU1571399168.USD","LU0058720904.USD","LU2552382215.SGD","IE00B2B36J28.USD","BK4554","IE00BJT1NW94.SGD","BK4139","LU0122379950.USD","IE0009355771.USD","BK4534","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2089984988.USD","BK4581","BK4533","BIB","STZ","IE0002141913.USD","BK4588","IE00BFTCPJ56.SGD","IBBQ","SG9999001440.SGD","BK4608","BBH","LU2552382132.HKD","LU2112291526.USD","LU1023059063.AUD","TBXU","LU2468319806.SGD","LU0868494617.USD","LU1983299246.USD","LU1061106388.HKD","BK4559","LU1057294990.SGD","IE00B4R5TH58.HKD","PBE","BK4585","LU2552382058.USD","BK4116","LU2242646821.SGD","LU0889565916.HKD","BK4169","PJP","IBB","LU0320765992.SGD","BK4599","BK4504","AMGN","BK4613"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}